Bruker Corporation (BRKR)
NASDAQ: BRKR · Real-Time Price · USD
37.52
-2.99 (-7.38%)
At close: May 9, 2025, 4:00 PM
38.55
+1.03 (2.75%)
After-hours: May 9, 2025, 4:01 PM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
| Total BSI | 3.19B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total BSI Growth | 17.08% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BEST | 269.20M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BEST Growth | -7.68% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Eliminations from | -14.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Eliminations from Growth | -12.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BSI Life Science | 2.08B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BSI Life Science Growth | 18.48% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BSI Nano | 1.11B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BSI Nano Growth | 14.58% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BSI BioSpin | 930.70M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BSI BioSpin Growth | 16.19% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BSI CALID | 1.15B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BSI CALID Growth | 20.40% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capex by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2011 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2011 - 2019 |
| Total BSI Capital Expenditures |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total BSI Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BEST Capital Expenditures |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BEST Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BSI Life Science Capital Expenditures |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BSI Life Science Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BSI Nano Capital Expenditures |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BSI Nano Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Capital Expenditures |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BSI BioSpin Capital Expenditures |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BSI BioSpin Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BSI CALID Capital Expenditures |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BSI CALID Capital Expenditures Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2011 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2011 - 2019 |
| Corporate, Eliminations and Other Operating Income |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate, Eliminations and Other Operating Income Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total BSI Operating Income |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total BSI Operating Income Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BEST Operating Income |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BEST Operating Income Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BSI Life Science Operating Income |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BSI Life Science Operating Income Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BSI Nano Operating Income |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BSI Nano Operating Income Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BSI BioSpin Operating Income |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BSI BioSpin Operating Income Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BSI CALID Operating Income |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BSI CALID Operating Income Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
| United States | 961.10M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 20.53% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Germany | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Germany Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Asia Pacific | 999.60M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Asia Pacific Growth | 2.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Countries | 261.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Countries Growth | 14.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Asia Pacific | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Asia Pacific Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|